Three new fusidic acid derivatives and their antibacterial activity

Bioorganic and Medicinal Chemistry Letters

Volumn 25, Issue 9, 2015, Pages 1920-1924

  Zhang, Shuwei ^a   Wang, Siyuan ^a   Zhang, Qian ^b   Chang, Cheng Wei Tom ^b   Zhan, Jixun ^a  

^a Utah State University   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

Antibacterial; Biotransformation; Dehydrogenation; Fusidic acid; Hapsidospora irregularis; Microbacterium oxydans

Indexed keywords

ANTIINFECTIVE AGENT; FUSIDIC ACID;

CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FUSIDIC ACID; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STAPHYLOCOCCUS AUREUS;

EID: 84937764298     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2015.03.033     Document Type: Article

References (16)

1. K. Lewis Nat. Rev. Drug Disc. 12 2013 371
2. D. Malloch, and R.F. Cain Can. J. Bot. 48 1970 1815
3. K. Hamano, M. Kinoshita, K. Furuya, M. Miyamoto, Y. Takamatsu, A. Hemmi, and K. Tanzawa J. Antibiot. 45 1992 899
4. K. Hamano, M. Kinoshita, K. Tanzawa, K. Yoda, Y. Ohki, T. Nakamura, and T. Kinoshita J. Antibiot. 45 1992 906
5. 4 in water) at 30 °C with shaking at 280 rpm for 7 days. The fermentation broth was centrifuged at 3500 rpm for 5 min to separate the supernatant and cells. The supernatant was loaded to a Diaion HP-20 column directly. The pelleted cells were extracted three times with 500 mL of methanol. After solvent evaporation, the residue was re-suspended in water and loaded to the same Diaion HP-20 column. The column was successively eluted with 0%, 25%, 50%, 75%, and 100% aqueous methanol. The target compounds were eluted by 50% aqueous methanol. This fraction was further separated on an Agilent 1200 HPLC using an Agilent Eclipse XDB C-18 (5 μm, 4.6 mm × 150 mm), eluted with 70% methanol-water at 1 mL/min. The peaks at 19.9 and 27.8 min were collected to yield 1 (110.0 mg) and 2 (11.5 mg) in pure form.
6. H.S. Burton, and E.P. Abraham Biochem. J. 50 1951 16874
7. T.-S. Chou, E.J. Eisenbraun, and R.T. Rapala Tetrahedron 25 1969 3341
8. A.C. Ritchie, N. Smith, and H.W. Florey Br. J. Pharmacol. Chemother. 6 1951 430
9. W. von Daehne, W.O. Godtfredsen, and P.R. Rasmussen Adv. Appl. Microbiol. 25 1979 95
10. J. Zhan, H. Guo, L. Ning, Y. Zhang, and D. Guo Planta Med. 72 2006 346
11. J. Zhan, H. Guo, J. Dai, Y. Zhang, and D. Guo Tetrahedron Lett. 43 2002 4519
12. A.J. O'Neill, J.M. Bostock, A. Morais Moita, and I. Chopra J. Antimicrob. Chemother. 50 2002 839
13. C. Yu, H. Xu, G. Huang, T. Chen, G. Liu, N. Chai, Y. Ji, S. Wang, Y. Dai, and S. Yuan Appl. Microbiol. Biotechnol. 86 2010 863
14. The biotransformation broth of 1 was harvested by centrifugation at 3500 rpm for 5 min. The supernatant was extracted three times with an equal volume of ethyl acetate. The solvent was evaporated in vacuo. The residue was re-dissolved in methanol and separated on an open MCI gel column, eluted with 0%, 25%, 50%, 75%, and 100% aqueous methanol to afford five fractions. The target compounds were eluted with 75% aqueous methanol. This fraction was then further separated on an Agilent 1200 HPLC using an Agilent Eclipse XDB C-18 (5 μm, 4.6 mm × 150 mm), eluted with 50% acetonitrile-water containing 0.05% formic acid at 1 mL/min. The peaks at 6.9, 9.5 and 13.6 min were collected to yield 5 (2.4 mg), 3 (15.4 mg) and 4 (6.5 mg) in pure form.
15. J. Zhan, W. Liu, H. Guo, Y. Zhang, and D. Guo Enzyme Microb. Technol. 33 2003 29
16. Escherichia coli XL-1 Blue, SA ATCC 25923 and MRSA ATCC 33591 were incubated in LB broth with the test samples at different concentrations (125, 64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125, and 0.064 μg/mL) at 37 C in 96-well plates, and the growth was analyzed after 20 h.